-
2601
Temporal change in average visitor vitality.
Published 2024“…The conclusions are as follows: (1)Park vitality varied dramatically between different periods, with park vitality being higher on holidays than on weekdays. …”
-
2602
Data source.
Published 2024“…The conclusions are as follows: (1)Park vitality varied dramatically between different periods, with park vitality being higher on holidays than on weekdays. …”
-
2603
Baidu heat map average.
Published 2024“…The conclusions are as follows: (1)Park vitality varied dramatically between different periods, with park vitality being higher on holidays than on weekdays. …”
-
2604
Supplementary materials for PhD thesis - "Understanding ⁴⁰Ar/³⁹Ar age variations in basaltic lavas"
Published 2025“…A criteria for assessing the reliability of an <sup>40</sup>Ar/<sup>39</sup>Ar age is proposed to evaluate each <sup>40</sup>Ar/<sup>39</sup>Ar age, which has decreased the inter-lava <sup>40</sup>Ar/<sup>39</sup>Ar age variability. …”
-
2605
Overview of the study area.
Published 2024“…The conclusions are as follows: (1)Park vitality varied dramatically between different periods, with park vitality being higher on holidays than on weekdays. …”
-
2606
Single factor detection results.
Published 2024“…The conclusions are as follows: (1)Park vitality varied dramatically between different periods, with park vitality being higher on holidays than on weekdays. …”
-
2607
Types of interaction between two factors.
Published 2024“…The conclusions are as follows: (1)Park vitality varied dramatically between different periods, with park vitality being higher on holidays than on weekdays. …”
-
2608
Research frameworks.
Published 2024“…The conclusions are as follows: (1)Park vitality varied dramatically between different periods, with park vitality being higher on holidays than on weekdays. …”
-
2609
Table 1_Case report: Clinical and immunohistochemical manifestations of suspected Sjogren's disease in a dog.xlsx
Published 2024“…Ocular discomfort improved dramatically decreasing the need for topical lubricants; however, tear production failed to improve likely due to extensive lacrimal gland atrophy. …”
-
2610
Model index comparison.
Published 2024“…The conclusions are as follows: (1)Park vitality varied dramatically between different periods, with park vitality being higher on holidays than on weekdays. …”
-
2611
Image 1_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff
Published 2025“…These results were confirmed by increased P4504A11 protein levels and decreased P4504F2 protein levels during the development and progression of MASLD. …”
-
2612
Image 5_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff
Published 2025“…These results were confirmed by increased P4504A11 protein levels and decreased P4504F2 protein levels during the development and progression of MASLD. …”
-
2613
Table 1_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.docx
Published 2025“…These results were confirmed by increased P4504A11 protein levels and decreased P4504F2 protein levels during the development and progression of MASLD. …”
-
2614
Image 2_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff
Published 2025“…These results were confirmed by increased P4504A11 protein levels and decreased P4504F2 protein levels during the development and progression of MASLD. …”
-
2615
Image 4_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff
Published 2025“…These results were confirmed by increased P4504A11 protein levels and decreased P4504F2 protein levels during the development and progression of MASLD. …”
-
2616
Image 9_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff
Published 2025“…These results were confirmed by increased P4504A11 protein levels and decreased P4504F2 protein levels during the development and progression of MASLD. …”
-
2617
Image 8_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff
Published 2025“…These results were confirmed by increased P4504A11 protein levels and decreased P4504F2 protein levels during the development and progression of MASLD. …”
-
2618
Image 7_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff
Published 2025“…These results were confirmed by increased P4504A11 protein levels and decreased P4504F2 protein levels during the development and progression of MASLD. …”
-
2619
Table 1_Schistosomiasis in Ghana from baseline to now: the impact of fifteen years of interventions.docx
Published 2025“…Prevalence of schistosomiasis decreased dramatically at first impact assessment, with overall prevalence at 3.5% (95% CI 2.6–4.7) and remained low in recent surveys at 6.8% (95% CI 6.1–7.6), which represents a 67.8% reduction from baseline to current prevalence.…”
-
2620
Image 11_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff
Published 2025“…These results were confirmed by increased P4504A11 protein levels and decreased P4504F2 protein levels during the development and progression of MASLD. …”